The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers

Pharmaceutical Research

Volumn 27, Issue 1, 2010, Pages 175-186

  Ehtezazi, T ^a   Saleem, I ^a   Shrubb, I ^b   Allanson, D R ^a   Jenkinson, I D ^a   O'Callaghan, C ^c  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Acute asthma exacerbations; Inter subject inhaled dose variability; Oropharyngeal models; Pressurised metered dose inhalers; Ultrafine aerosols

Indexed keywords

CORTICOSTEROID;

ADULT; AEROSOL; ARTICLE; GEOMETRY; HUMAN; METERED DOSE INHALER; OROPHARYNX; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; DRUG DELIVERY SYSTEMS; HUMANS; INHALATION SPACERS; METERED DOSE INHALERS; MODELS, ANATOMIC; OROPHARYNX; PARTICLE SIZE; SUSPENSIONS; TISSUE DISTRIBUTION;

EID: 72949109105     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9994-z     Document Type: Article

References (35)

1. BL Laube 2005 The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination Respir Care 50 1161 76 16122400
2. JP Karpel TK Aldrich DJ Prezant K Guguchev A Gaitan-Salas R Pathiparti 1997 Emergency treatment of acute asthma with albuterol metered-dose inhaler plus holding chamber: how often should treatments be administered? Chest 112 348 56 10.1378/chest.112.2.348 9266868
3. MB Dolovich RC Ahrens DR Hess P Anderson R Dhand JL Rau GC Smaldone G Guyatt 2005 American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology Chest 127 335 71 10.1378/chest.127.1.335 15654001 (Pubitemid 41724594)
4. SJ Szefler RJ Martin TS King HA Boushey RM Cherniack VM Chinchilli TJ Craig M Dolovich JM Drazen JK Fagan JV Fahy JE Fish JG Ford E Israel J Kiley M Kraft SC Lazarus RF Lemanske Jr E Mauger SP Peters CA Sorkness 2002 Asthma Clinical Research Network of the National Heart Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma J Allergy Clin Immunol. 109 410 8 10.1067/mai.2002.122635 11897984 (Pubitemid 34234189)
5. L Borgström E Derom E Ståhl E Wåhlin-Boll R Pauwels 1996 The inhalation device influences lung deposition and bronchodilating effect of terbutaline Am J Respir Crit Care Med. 153 1636 40 8630614
6. L Borgström B Olsson L Thorsson 2006 Degree of throat deposition can explain the variability in lung deposition of inhaled drugs J Aerosol Med. 19 473 83 10.1089/jam.2006.19.473 17196076 (Pubitemid 46067766)
7. C Dunbar G Scheuch K Sommerer M DeLong A Verma R Batycky 2002 In vitro and in vivo dose delivery characteristics of large porous particles for inhalation Int J Pharm. 245 179 89 10.1016/S0378-5173(02)00349-6 12270254 (Pubitemid 35299903)
8. K Svartengren P Lindestad M Svartengren K Philipson G Bylin P Camner 1995 Added external resistance reduces oropharyngeal deposition and increases lung deposition of aerosol particles in asthmatics Am J Respir Crit Care Med. 152 32 7 7599841
9. K Svartengren M Anderson M Svartengren K Philipson P Camner 1996 Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece Eur Respir J. 9 1556 9 10.1183/09031936.96.09061123 8836672 (Pubitemid 26231723)
10. K De Boeck M Alifier G Warnier 1999 Is the correct use of a dry powder inhaler (Turbohaler) age dependent? J Allergy Clin Immunol. 103 763 7 10.1016/S0091-6749(99)70417-3 10329807 (Pubitemid 29297576)
11. PK Burnell L Asking L Borgström SC Nichols B Olsson D Prime I Shrubb 2007 Studies of the human oropharyngeal airspaces using magnetic resonance imaging IV-the oropharyngeal retention effect for four inhalation delivery systems J Aerosol Med. 20 269 81 10.1089/jam.2007.0566 17894534 (Pubitemid 47463183)
12. T Ehtezazi DR Allanson ID Jenkinson C O'Callaghan 2006 Effect of oropharyngeal length in drug lung delivery via suspension pressurized metered dose inhalers Pharm Res. 23 1364 72 10.1007/s11095-006-0163-3 16715362 (Pubitemid 43946158)
13. HM Janssens JC De Jongste WC Hop HA Tiddens 2003 Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model Chest 123 2083 8 10.1378/chest.123.6.2083 12796192 (Pubitemid 36706736)
14. CL Leach PJ Davidson BE Hasselquist RJ Boudreau 2002 Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers Chest 122 510 6 10.1378/chest.122.2.510 12171824 (Pubitemid 35002128)
15. T Ehtezazi MA Horsfield PW Barry C O'Callaghan 2004 Dynamic change of the upper airway during inhalation via aerosol delivery devices J Aerosol Med. 17 325 34 10.1089/jam.2004.17.325 15684732 (Pubitemid 40116949)
16. T Ehtezazi KW Southern D Allanson I Jenkinson C O'Callaghan 2005 Suitability of the upper airway models obtained from MRI studies in simulating drug lung deposition from inhalers Pharm Res. 22 166 70 10.1007/s11095-004-9023- 1 15771244 (Pubitemid 40558160)
17. TC Lin PN Breysse BL Laube DL Swift 2001 Mouthpiece diameter affects deposition efficiency in cast models of the human oral airways J Aerosol Med. 14 335 41 10.1089/089426801316970295 11693845
18. JH Wildhaber SG Devadason E Eber MJ Hayden ML Everard QA Summers PN LeSouëf 1996 Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants Thorax 51 985 8 10.1136/thx.51.10.985 8977597
19. PJ Mitchell MW Nagel KJ Wiersema CC Doyle 2003 Aerodynamic particle size analysis of aerosols from pressurised metered dose inhalers: Comparison of Anderson 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer AAPS PharmSciTech 4 1 9 10.1208/pt040454
20. B Volovitz E Bilavsky M Nussinovitch 2008 Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children J Asthma. 45 561 7 10.1080/02770900802005251 18773327
21. British Thoracic Society Scottish Intercollegiate Guidelines Network 2008 British Guideline on the Management of Asthma Thorax 63 iv1 121 10.1136/thx.2008.097741 (Pubitemid 351692371)
22. BK Nyambura IW Kellaway KM Taylor 2009 Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers Int J Pharm. 375 114 1122 10.1016/j.ijpharm.2009.03.031 19481697
23. L Wu M Al-Haydari SR da Rocha 2008 Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes Eur J Pharm Sci. 33 146 58 10.1016/j.ejps.2007.10.007 18083015
24. AR Martin WH Finlay 2005 The effect of humidity on the size of particles delivered from metered-dose inhalers Aerosol Sci Tech. 39 283 9
25. TB Martonen KA Bell RF Phalen AF Wilson A Ho 1982 Growth rate measurements and deposition modelling of hygroscopic aerosols in human tracheobronchial models Ann Occup Hyg. 26 93 108 10.1093/annhyg/26.1.93 7181315
26. AJ Hickey TB Martonen 1993 Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives Pharm Res. 10 1 7 10.1023/A:1018952425107 8430044 (Pubitemid 23020830)
27. J Garrett S Williams C Wong D Holdaway 1998 Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid Arch Dis Child. 79 12 7 10.1136/adc.79.1.12 9771245
28. K Svartengren K Philipson M Svartengren M Anderson P Camner 1996 Tracheobronchial deposition and clearance in small airways in asthmatic subjects Eur Respir J. 9 1118 22 10.1183/09031936.96.09061123 (Pubitemid 26231723)
29. O Aswania S Ritson SM Iqbal J Bhatt AS Rigby ML Everard 2004 Intra-subject variability in lung dose in healthy volunteers using five conventional portable inhalers J Aerosol Med. 17 231 8 10.1089/jam.2004.17.231 15625815 (Pubitemid 39299324)
30. L Borgström T Bengtsson E Derom R Pauwels 2000 Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler Int J Pharm. 193 227 30 10.1016/S0378-5173(99)00341-5 10606786 (Pubitemid 30001866)
31. OS Usmani MF Biddiscombe PJ Barnes 2005 Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size Am J Respir Crit Care Med. 172 1497 504 10.1164/rccm.200410-1414OC 16192448 (Pubitemid 43076536)
32. SH Mazhar NE Ismail DA Newton H Chrystyn 2008 Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation Br J Clin Pharmacol. 65 334 7 10.1111/j.1365-2125.2007.03036.x 17922883 (Pubitemid 351316916)
33. CM Roller G Zhang RG Troedson CL Leach PN Le Souëf SG Devadason 2007 Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children Eur Respir J. 29 299 306 10.1183/09031936.00051106 17005581 (Pubitemid 46231907)
34. J Onhøj L Thorsson H Bisgaard 2000 Lung deposition of inhaled drugs increases with age Am J Respir Crit Care Med. 162 1819 22 11069819
35. H Smyth AJ Hickey G Brace T Barbour J Gallion J Grove 2006 Spray pattern analysis for metered dose inhalers I: orifice size, particle size, and droplet motion correlations Drug Dev Ind Pharm. 32 1033 41 10.1080/03639040600637598 17012116 (Pubitemid 44521821)